A hybrid phantom Monte Carlo-based method for historical reconstruction of organ doses in patients treated with cobalt-60 for Hodgkin's lymphoma

被引:4
|
作者
Petroccia, Heather [1 ]
Mendenhall, Nancy [2 ]
Liu, Chihray [2 ]
Hammer, Clifford [3 ]
Culberson, Wesley [3 ]
Thar, Tim [2 ]
Mitchell, Tom [2 ]
Li, Zuofeng [4 ]
Bolch, Wesley [1 ]
机构
[1] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA
[2] Univ Florida, Coll Med, Dept Radiat Oncol, Gainesville, FL USA
[3] Univ Wisconsin, Dept Med Phys, Sch Med & Publ Hlth, 1530 Med Sci Ctr, Madison, WI 53706 USA
[4] Univ Florida, Proton Therapy Inst, Jacksonville, FL USA
关键词
Monte Carlo; organ dosimetry; dose reconstruction; Hodgkin's lymphoma; computational phantom; RADIATION-THERAPY; RADIOTHERAPY; CANCER; PHOTON; RISK; DISEASE; CHEMOTHERAPY; SIMULATION; EXPOSURES; MACHINES;
D O I
10.1088/1361-6560/aa7c2f
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Historical radiotherapy treatment plans lack 3D images sets required for estimating mean organ doses to patients. Alternatively, Monte Carlo-based models of radiotherapy devices coupled with whole-body computational phantoms can permit estimates of historical in-field and out-of-field organ doses as needed for studies associating radiation exposure and late tissue toxicities. In recreating historical patient treatments with Co-60 based systems, the major components to be modeled include the source capsule, surrounding shielding layers, collimators (both fixed and adjustable), and trimmers as needed to vary field size. In this study, a computational model and experimental validation of the Theratron T-1000 are presented. Model validation is based upon in-field commissioning data collected at the University of Florida, published out-offield data from the British Journal of Radiology (BJR) Supplement 25, and out-of-field measurements performed at the University of Wisconsin's Accredited Dosimetry Calibration Laboratory (UWADCL). The computational model of the Theratron T-1000 agrees with central axis percentage depth dose data to within 2% for 6 x 6 to 30 x 30 cm(2) fields. Out-of-field doses were found to vary between 0.6% to 2.4% of central axis dose at 10 cm from field edge and 0.42% to 0.97% of central axis dose at 20 cm from the field edge, all at 5 cm depth. Absolute and relative differences between computed and measured out-of-field doses varied between +/- 2.5% and +/- 100%, respectively, at distances up to 60 cm from the central axis. The source-term model was subsequently combined with patient-morphometry matched computational hybrid phantoms as a method for estimating in-field and out-of-field organ doses for patients treated for Hodgkin's Lymphoma. By changing field size and position, and adding patient-specific field shaping blocks, more complex historical treatment set-ups can be to recreated, particularly those for which 2D or 3D image sets are unavailable.
引用
收藏
页码:6261 / 6289
页数:29
相关论文
共 1 条
  • [1] Therapeutic potential of 90Y- and 131I-labeled anti-CD20 monoclonal antibody in treating non-Hodgkin's lymphoma with pulmonary involvement:: A Monte Carlo-based dosimetric analysis
    Song, Hong
    Du, Yong
    Sgouros, George
    Prideaux, Andrew
    Frey, Eric
    Wahl, Richard L.
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (01) : 150 - 157